New Delhi, February 16 Drug firm Lupin announced on Monday that it has signed a licensing and supply agreement with Spektus Pharma to commercialize the novel antidepressant DeslaFlex in Canada.The strategic partnership combines Lupin's strong commercial presence in Canada and Spektus's...